Blog – Practical strategies for stable, biologically neutral cell Line barcoding
Assigning a unique molecular identity to an engineered cell line opens up new possibilities for traceability, provenance and version control. For organisations investing months or years in developing an engineered cell line, introducing a Genosignature® typically represents only a small additional engineering effort. In doing so it provides a permanent molecular identity that supports provenance, […]
Case Study – Biosecurity and Chain-of-Custody Verification
By Dr Neil Williamson – NW Bio-X Ltd Strain identity and protocol traceability, addressed in the two case studies above, primarily protect an organisation’s own record of its R&D investment. A third dimension of the provenance problem is external: demonstrating to a regulator, a commercial partner, or the public that a specific organism is what […]
Blog – Practical strategies for stable, biologically neutral cell Line barcoding
Assigning a unique molecular identity to an engineered cell line opens up new possibilities for traceability, provenance and version control. For organisations investing months or years in developing an engineered cell line, introducing a Genosignature® typically represents only a small additional engineering effort. In doing so it provides a permanent molecular identity that supports provenance, […]
Case Study – Version Controlling a CRISPR-Cas9 editing protocol
By Dr Neil Williamson from NW Bio-X Limited Strain identity is one half of the data management problem. The other is the protocol itself: the method that must perform consistently regardless of who runs it, which reagents they use, or which instrument they work on. The composite illustrative case study below demonstrates that CellRepo has […]
Case Study – Strain development from pathway to CDMO scale-up
By Dr Neil Williamson from NW Bio-X Limited The operational impact of data management failures is most clearly traced through a real engineering biology workflow. The composite illustrative case study below is based on common patterns observed across multiple engineering biology organisations. It does not represent any single company or project. Composite Illustrative Case Study […]
White Paper: The missing layer in biology’s data revolution by NW Bio-X
As engineering biology enters the age of AI, the quality, traceability, and integrity of scientific data have become critical competitive advantages. This white paper explores why fragmented laboratory records, disconnected datasets, and poor provenance tracking remain major barriers to reproducibility, technology transfer, regulatory compliance, and AI-driven discovery. It argues that version control—long established in software […]
Blog: How IP disputes in synthetic biology actually play out
And why GitLife Biotech is part of this conversation In synthetic biology, intellectual property disputes are rarely decided by patents alone. They are fought, and often won, on the strength of evidence. Not just whether you own an invention, but whether you can prove what happened to it: when it was created, who accessed it […]
Blog: Genosignatures vs Whole Genome Sequencing: Why Identity Matters More Than Resolution
In our previous blog (view here), we introduced Genosignatures as a way of embedding identity directly into living cells. That idea is intuitive on its own, but it raises a natural question: if we can already sequence an entire genome, why introduce anything new? At first glance, whole genome sequencing (WGS) appears to do everything. […]
CellRepo Launches in Beta Across the Synthetic Biology Community
GitLife has announced the beta availability of CellRepo, our cloud-based version control system for biological engineering, with deployments now underway across the synthetic biology community. CellRepo introduces a new infrastructure layer for biotechnology: version control for living systems. Inspired by software development practices, the platform enables researchers and companies to track, manage, and verify the […]
BLOG: Genosignatures® – How GitLife embeds identity and trust directly into DNA
As biology becomes easier to engineer, and more and more engineered biology is being created, a fundamental problem has quietly emerged: living cells do not carry reliable proof of how they were built, who built them or where they came from. Labels get lost. Files drift out of sync. Documentation breaks as strains move between […]